Literature DB >> 11932201

The molecular basis of Streptococcus equi infection and disease.

Dean J Harrington1, Iain C Sutcliffe, Neil Chanter.   

Abstract

Streptococcus equi is the aetiological agent of strangles, one of the most prevalent diseases of the horse. The animal suffering and economic burden associated with this disease necessitate effective treatment. Current antibiotic therapy is often ineffective and thus recent attention has focused on vaccine development. A systematic understanding of S. equi virulence, leading to the identification of targets to which protective immunity can be directed, is a prerequisite of the development of such a vaccine. Here, the virulence factors of S. equi are reviewed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932201     DOI: 10.1016/s1286-4579(02)01565-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  23 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Authors:  Andrea Hamilton; Carl Robinson; Iain C Sutcliffe; Josh Slater; Duncan J Maskell; Nick Davis-Poynter; Ken Smith; Andrew Waller; Dean J Harrington
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

3.  Antiphagocytic function of an IgG glycosyl hydrolase from Streptococcus equi subsp. equi and its use as a vaccine component.

Authors:  Margareta Flock; Lars Frykberg; Markus Sköld; Bengt Guss; Jan-Ingmar Flock
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

Review 4.  Streptolysin S-like virulence factors: the continuing sagA.

Authors:  Evelyn M Molloy; Paul D Cotter; Colin Hill; Douglas A Mitchell; R Paul Ross
Journal:  Nat Rev Microbiol       Date:  2011-08-08       Impact factor: 60.633

5.  Reduced thrombin generation increases host susceptibility to group A streptococcal infection.

Authors:  Hongmin Sun; Xixi Wang; Jay L Degen; David Ginsburg
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

6.  Esterase SeE of Streptococcus equi ssp. equi is a novel nonspecific carboxylic ester hydrolase.

Authors:  Gang Xie; Mengyao Liu; Hui Zhu; Benfang Lei
Journal:  FEMS Microbiol Lett       Date:  2008-12       Impact factor: 2.742

7.  Cofactor requirement of HpyAV restriction endonuclease.

Authors:  Siu-Hong Chan; Lars Opitz; Lauren Higgins; Diana O'loane; Shuang-Yong Xu
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

8.  IgG Endopeptidase SeMac does not Inhibit Opsonophagocytosis of Streptococcus equi Subspecies equi by Horse Polymorphonuclear Leukocytes.

Authors:  Mengyao Liu; Benfang Lei
Journal:  Open Microbiol J       Date:  2010-04-08

9.  Genotypic and Phenotypic Assessment of Hyaluronidase among Type Strains of a Select Group of Staphylococcal Species.

Authors:  Mark E Hart; Morgan J Hart; Anna J Roop
Journal:  Int J Microbiol       Date:  2010-01-10

10.  Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi.

Authors:  J Todd Hoopes; Caren J Stark; Han Ah Kim; Daniel J Sussman; David M Donovan; Daniel C Nelson
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.